Crossmark

Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer

Crossref DOI link: https://doi.org/10.1007/s00066-024-02333-4

Published Online: 2024-12-10

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsurugai, Yuichiro https://orcid.org/0000-0003-0872-2000
Takeda, Atsuya

Sanuki, Naoko

Aoki, Yousuke

Kimura, Yuto

Oku, Yohei

Eriguchi, Tomohiro

Yamanaka, Hiroyuki

Machida, Maiko

Matsushita, Tomohiko

Saito, Shiro
License Information

Text and Data Mining valid from 2024-12-10

Version of Record valid from 2024-12-10
More Information

Article History

Received: 31 July 2024

Accepted: 10 November 2024

First Online: 10 December 2024

Conflict of interest

: Y. Tsurugai, A. Takeda, N. Sanuki, Y. Aoki, Y. Kimura, Y. Oku, T. Eriguchi, H. Yamanaka, M. Machida, T. Matsushita, and S. Saito declare that they have no competing interests.

Document is current

Any future updates will be listed below